Wegovy vs Zepbound in 2026: Side by Side Comparison of the Two Leading Weight Loss Drugs
Updated June 2026 · Reviewed by the MealFan editorial team
Head to head comparison
| Factor | Wegovy | Zepbound |
|---|---|---|
| Molecule | Semaglutide | Tirzepatide |
| Mechanism | GLP 1 agonist | Dual GIP + GLP 1 agonist |
| Manufacturer | Novo Nordisk | Eli Lilly |
| FDA approval (weight) | June 2021 | November 2023 |
| Trial weight loss (avg) | 14.9% at 68 weeks (STEP 1) | 20.9% at 72 weeks (SURMOUNT 1) |
| Real-world weight loss | 9.1% at 12 months (Truveta) | 12.4% at 12 months (Truveta) |
| Dose escalation steps | 0.25 to 2.4 mg (5 steps over 16 weeks) | 2.5 to 15 mg (6 steps over 20 weeks) |
| Nausea rate | 44.2% | 39.0% |
| Discontinuation rate | 7.0% | 6.2% |
| Monthly cost (no insurance) | $1,349 | $1,059 |
| Eli Lilly Direct (cash) | N/A | $349-$549/mo for vials |
Weight loss: head to head
In the SURMOUNT 5 trial published in 2024, Zepbound was compared directly against Wegovy in the same patient population. Zepbound showed 47 percent more weight loss than Wegovy at 72 weeks. This is the cleanest head-to-head comparison available.
However, real-world data narrows the gap. Truveta's 2024 cohort analysis showed 12.4 percent at 12 months for Zepbound vs 9.1 percent for Wegovy. The 3.3 percentage point real-world gap is smaller than the trial gap because real-world adherence and dose escalation are limited for both medications.
Side effects: which is more tolerable
Despite Zepbound's stronger effect, side effect rates are similar or slightly lower than Wegovy in the FDA prescribing information data. This is a counterintuitive finding because more potent medications typically have more side effects. The dual GIP + GLP 1 mechanism may produce smoother appetite suppression and less aggressive GI side effects.
Practically, most patients tolerate both medications similarly in the first 4 to 8 weeks. Beyond that, individual response varies significantly.
Cost: Zepbound is meaningfully cheaper in 2026
Eli Lilly launched a direct-to-consumer program for Zepbound in 2024, offering vials at $349 to $549 per month depending on dose. This is significantly cheaper than Wegovy's list price of $1,349 per month or even with most discount cards. For cash payers, Zepbound is now the better choice on cost alone.
For insured patients, coverage varies. Wegovy has been covered longer and has broader formulary acceptance. Zepbound coverage is growing in 2026.
Who should choose which
Choose Wegovy if:
- Your insurance covers Wegovy but not Zepbound
- You have already been on semaglutide (Ozempic) and tolerated it well
- You want the medication with the longer real-world track record
Choose Zepbound if:
- Maximum weight loss is your primary goal
- You are paying cash (Eli Lilly Direct is meaningfully cheaper)
- You have struggled to tolerate semaglutide and want to try a different mechanism
- Your BMI is 35+ and you want the more potent option
Meal delivery for Wegovy or Zepbound users
Food guidance is similar for both medications. The services below have high protein options that match the eating patterns most users need on either drug.
- Factor. Protein Plus line works for both. $11.49 per meal.
- Trifecta. Best macro accuracy. $14.99 per meal.
- CookUnity. Chef rotation, $11.99 per meal.
See our GLP 1 meal delivery hub for the full ranking.
Wegovy vs Zepbound FAQ
Which is better, Wegovy or Zepbound?
For pure weight loss, Zepbound shows larger average outcomes (20.9 percent vs 14.9 percent at maximum doses). For cost without insurance, Zepbound is also cheaper through Eli Lilly Direct. Wegovy has the longer real-world track record and broader insurance coverage.
Is Zepbound more powerful than Wegovy?
Yes. Zepbound (tirzepatide) is a dual GIP and GLP 1 receptor agonist while Wegovy (semaglutide) only acts on GLP 1. Head to head SURMOUNT 5 trial data shows Zepbound produces 47 percent more weight loss than Wegovy.
Are side effects worse on Zepbound?
Surprisingly, no. Side effect rates including nausea, vomiting, and diarrhea are similar or slightly lower on Zepbound vs Wegovy per FDA prescribing data. The dual mechanism may produce smoother appetite suppression.
Can I switch from Wegovy to Zepbound?
Yes, with prescriber guidance. The switch is common in 2026. Most clinicians wait 1 to 2 weeks after the last Wegovy injection, then start Zepbound at the 2.5 mg starter dose to allow appetite suppression to reset.
Which is cheaper, Wegovy or Zepbound?
Zepbound is cheaper in 2026. Eli Lilly Direct offers Zepbound vials at $349 to $549 per month vs Wegovy's list price of $1,349 per month. For insured patients, coverage varies.
Related guides
- GLP-1 statistics 2026: prescription growth and clinical trial data.
- Real-world weight loss data: trial vs patient outcomes.
- What to eat on Wegovy.
- What to eat on Zepbound.
See also: Mounjaro vs. Wegovy Meal Delivery, GLP-1 comparison guide
See also: Zepbound vs. Ozempic Meal Delivery, GLP-1 drug meal guide
See also: Ozempic vs. Mounjaro Meal Delivery, related weight-loss drug comparison
Read Our Full Reviews
Related Guides
- Best Meal Delivery for Vegan
- Best Meal Delivery for Low Carb
- 8 Best Meal Kit Delivery for Mediterranean Diet
- 8 Best Paleo Meal Delivery Services (2026): Tested & Ranked
Find your meal kit in 2 minutes
Answer 5 quick questions. We'll match you to the top 3 from 24 services we track.
Popular comparisons
Compare across all our rankings
- Best Meal Delivery Services of 2026: our master ranking of the top 10 services in the United States.
- Best High Protein Meal Delivery: ranked for athletes, weight management, and GLP 1 friendly meals.
- Best Diabetic Meal Delivery: ranked for Type 2 diabetes, pre diabetes, and insulin support.
- Best GLP 1 Meal Delivery: ranked for Ozempic, Wegovy, Mounjaro, and Zepbound users.
